C E Halstenson

1.1k total citations
28 papers, 836 citations indexed

About

C E Halstenson is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, C E Halstenson has authored 28 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Infectious Diseases. Recurrent topics in C E Halstenson's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Antibiotic Resistance in Bacteria (5 papers). C E Halstenson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Antibiotic Resistance in Bacteria (5 papers). C E Halstenson collaborates with scholars based in United States and Germany. C E Halstenson's co-authors include Gary R. Matzke, W. F. Keane, R. McGory, John A. Opsahl, Paul A. Abraham, William F. Keane, Walid M. Awni, JoAnn M. Sperl‐Hillen, Patrick J. O’Connor and David R.P. Guay and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of the American Society of Nephrology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C E Halstenson

28 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C E Halstenson United States 14 390 269 191 110 103 28 836
Steven C. Boike United States 16 307 0.8× 280 1.0× 153 0.8× 75 0.7× 128 1.2× 36 934
Kyle Vance‐Bryan United States 15 408 1.0× 314 1.2× 232 1.2× 60 0.5× 147 1.4× 35 886
J P Fillastre France 18 477 1.2× 93 0.3× 218 1.1× 129 1.2× 49 0.5× 75 1.0k
Kenneth E. Record United States 14 261 0.7× 177 0.7× 111 0.6× 72 0.7× 81 0.8× 33 693
Shuchean Chien United States 12 455 1.2× 135 0.5× 305 1.6× 98 0.9× 41 0.4× 14 896
F Vauzelle-Kervroëdan France 17 258 0.7× 103 0.4× 399 2.1× 217 2.0× 90 0.9× 38 1.3k
Pramodini Kale-Pradhan United States 20 167 0.4× 242 0.9× 236 1.2× 51 0.5× 56 0.5× 72 1.3k
Raffaele De Gaudio Italy 10 165 0.4× 136 0.5× 353 1.8× 36 0.3× 48 0.5× 18 874
Athena F. Zuppa United States 23 408 1.0× 179 0.7× 274 1.4× 370 3.4× 56 0.5× 122 1.7k
Dennis J. Stalker United States 12 570 1.5× 675 2.5× 141 0.7× 56 0.5× 299 2.9× 21 1.2k

Countries citing papers authored by C E Halstenson

Since Specialization
Citations

This map shows the geographic impact of C E Halstenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Halstenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Halstenson more than expected).

Fields of papers citing papers by C E Halstenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C E Halstenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Halstenson. The network helps show where C E Halstenson may publish in the future.

Co-authorship network of co-authors of C E Halstenson

This figure shows the co-authorship network connecting the top 25 collaborators of C E Halstenson. A scholar is included among the top collaborators of C E Halstenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C E Halstenson. C E Halstenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sperl‐Hillen, JoAnn M., et al.. (2000). Improving Diabetes Care in a Large Health Care System: An Enhanced Primary Care Approach. The Joint Commission Journal on Quality Improvement. 26(11). 615–622. 80 indexed citations
3.
Eldon, Michael A., William F. Keane, Dominique Turck, et al.. (1995). Disposition of Gabapentin in Anuric Subjects on Hemodialysis. The Journal of Clinical Pharmacology. 35(6). 622–626. 59 indexed citations
4.
Peter, John V. St., Michael Emmett Brady, Edward F. Foote, et al.. (1993). The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment. European Journal of Clinical Pharmacology. 45(1). 59–63. 2 indexed citations
5.
Halstenson, C E, et al.. (1992). Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease. Antimicrobial Agents and Chemotherapy. 36(9). 1832–1836. 10 indexed citations
6.
Barbhaiya, Rashmi H., C A Knupp, S. Thomas Forgue, et al.. (1991). Disposition of the cephalosporin cefepime in normal and renally impaired subjects.. Drug Metabolism and Disposition. 19(1). 68–73. 45 indexed citations
7.
Kelloway, J S, Walid M. Awni, Cheng‐Chieh Lin, et al.. (1991). Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency. Antimicrobial Agents and Chemotherapy. 35(11). 2267–2274. 19 indexed citations
8.
Keane, William F., Milton L. Bullock, Arthur L. Ney, et al.. (1991). Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure.. Journal of the American Society of Nephrology. 2(4). 841–847. 10 indexed citations
9.
Awni, Walid M., Jen Yeh, C E Halstenson, et al.. (1990). Effect of haemodialysis on the pharmacokinetics of cetirizine. European Journal of Clinical Pharmacology. 38(1). 67–69. 14 indexed citations
10.
Halstenson, C E, et al.. (1990). Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease. Antimicrobial Agents and Chemotherapy. 34(1). 128–133. 18 indexed citations
11.
Apple, Fred S., Peter Benson, Paul A. Abraham, T G Rosano, & C E Halstenson. (1989). Assessment of renal function by inulin clearance: comparison with creatinine clearance as determined by enzymatic methods.. Clinical Chemistry. 35(2). 312–314. 13 indexed citations
12.
Opsahl, John A., et al.. (1988). Correlation of Office and Ambulatory Blood Pressure Measurements with Urinary Albumin and N-Acetyl- D-Glucosaminidase Excretions in Essential Hypertension. American Journal of Hypertension. 1(3 Pt 3). 117S–120S. 70 indexed citations
13.
Guay, David R.P., Walid M. Awni, C E Halstenson, et al.. (1987). Pharmacokinetics of Codeine After Single‐and Multiple‐Oral‐Dose Administration to Normal Volunteers. The Journal of Clinical Pharmacology. 27(12). 983–987. 35 indexed citations
14.
Matzke, Gary R., et al.. (1987). Systemic Absorption of Oral Vancomycin in Patients With Renal Insufficiency and Antibiotic-Associated Colitis. American Journal of Kidney Diseases. 9(5). 422–425. 27 indexed citations
15.
Halstenson, C E, et al.. (1986). Renal hemodynamic and humoral effects of pinacidil and hydralazine in essential hypertension. Clinical Pharmacology & Therapeutics. 39(2). 177. 2 indexed citations
16.
Heim-Duthoy, K L, C E Halstenson, Paul A. Abraham, & Gary R. Matzke. (1986). The effect of hemodialysis on piperacillin pharmacokinetics.. PubMed. 24(12). 680–4. 6 indexed citations
17.
Halstenson, C E, et al.. (1986). Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 30(1). 15–19. 5 indexed citations
18.
Halstenson, C E, et al.. (1984). Hemodialysis elimination rates and clearance of gentamicin and tobramycin. Antimicrobial Agents and Chemotherapy. 25(1). 128–130. 22 indexed citations
19.
Haughey, David B., Gary R. Matzke, C E Halstenson, & W. F. Keane. (1984). Analytical Specificity of Commercially Available Methods for Serum Phenytoin Determination. Journal of Analytical Toxicology. 8(3). 106–111. 1 indexed citations
20.
Halstenson, C E, et al.. (1984). Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.. PubMed. 22(5). 239–43. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven C. Boike Breakdown of academic impact, for papers by Kyle Vance‐Bryan Breakdown of academic impact, for papers by J P Fillastre Breakdown of academic impact, for papers by Kenneth E. Record Breakdown of academic impact, for papers by Shuchean Chien Breakdown of academic impact, for papers by F Vauzelle-Kervroëdan Breakdown of academic impact, for papers by Pramodini Kale-Pradhan Breakdown of academic impact, for papers by Raffaele De Gaudio Breakdown of academic impact, for papers by Athena F. Zuppa Breakdown of academic impact, for papers by Dennis J. Stalker
Rankless by CCL
2026